Use of procalcitonin as diagnostic marker in acute gastroenteritis
PDF (Español (España))

Keywords

Acute Gastroenteritis
Procalcitonin
C-Reactive Protein
Bacteria
Virus
Gastroenterology
Gastrointestinal Tract Infection
Gastroenteritis
Clinical Laboratory Techniques in Gastroenterology

How to Cite

1.
Martínez L. AB, Marañón P. R, Cobo E. PV, Tomatis S. C, Guerra M. L, Peñalba C. AC. Use of procalcitonin as diagnostic marker in acute gastroenteritis. Andes pediatr [Internet]. 2014 Apr. 6 [cited 2025 Nov. 18];85(2):157-63. Available from: https://andespediatrica.cl/index.php/rchped/article/view/3101

Abstract

Introduction: There is no hematological marker that reliably differentiates between bacterial and nonbacterial acute gastroenteritis (AGE).

The objective of this study is to evaluate procalcitonin (PCT) as a marker for bacterial AGE and analyze its relationship with hospital admission. 

Patients and Method: A prospective study of children diagnosed with AGE was conducted at the emergency room during a period of seven months, which required blood and stool samples. Epidemiological, clinical and analytical variables were analyzed. Patients with chronic digestive disease, prolonged diarrhea, immunodeficiency or prior antibiotic treatment were excluded. The study was approved by the Ethics Committee and an informed consent was requested. 

Results: 45 patients were analyzed. Children with bacterial GEA were older (p = 0.027) and presented higher median PCT and C-reactive protein concentrations (CRP) (p = 0.001). The PCT and CRP values that best discriminated bacterial infection were PCT ≥ 0.05 mg/L (sensibility 64.3%, specificity 83.9%, positive probability coefficient (PPC): 4), and CRP ≥ 3mg/dL (sensibility 78.6%, specificity 90.3%, PPC: 8). No association between the elevation of these markers and higher hospitalization probability was found. 

Conclusion: Procalcitonin, like CRP, is elevated in bacterial gastroenteritis (p = 0.001), but these markers are not a predictor of hospitalization.

PDF (Español (España))

Los contenidos publicados en esta revista están protegidos bajo una Licencia Creative Commons Atribución 4.0 Internacional (CC BY 4.0). Esto significa que cualquier persona es libre de compartir,  usar y construir a partir de este artículo, incluso con fines comerciales, siempre que se otorgue el crédito apropiado al autor original, se proporcione un enlace a la licencia, se indique el nombre y edición de la Revista.

Esta licencia no impone restricciones adicionales, lo que garantiza la libre circulación y reutilización del conocimiento con respeto y transparencia hacia los derechos de los autores.  (Véase El efecto del acceso abierto).